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Abstract: Transcervical extended mediastinal lymphadenectomy
(TEMLA) is a new surgical procedure for staging of the medi-
astinal lymph nodes in patients with non-small cell lung cancer
(NSCLC). The operation is performed through the 5- to 8-cm
collar incision in the neck and enables complete removal of all
mediastinal nodal stations except for the pulmonary ligament nodes
(station 9) and the most distal left paratracheal nodes (station 4L).
Generally, TEMLA is an open procedure performed partly with medi-
astinoscopy-assisted and videothoracoscopy-assisted techniques. Oper-
ative technique of TEMLA includes elevation of the sternal manubrium
with a special retractor and bilateral visualization of the laryngeal
recurrent and vagus nerves.
From January 1, 2004 to November 15, 2005, TEMLA was
performed in 256 patients. Length of operation was 80 to 330
minutes (mean, 161 minutes). Complication of TEMLA occurred in
11.3% of patients with temporary laryngeal nerve palsy in 6 of 256
patients (2.3%) and permanent nerve palsy in 2 of 256 patients
(0.8%). The number of dissected nodes during TEMLA was 15 to 85
(mean, 38.9). N2-3 nodes were found in 80 patients (31.3%). During
subsequent thoracotomy, omitted N2 nodes were found in 5 of 138
patients, and omitted normal mediastinal nodes were found in 13 of
138 patients (9.4%). Sensitivity of TEMLA in discovery of N2-3
nodes was 94.1%, specificity was 100%, accuracy was 98%, nega-
tive predictive value was 97.2%, and positive predictive value was
100%. Preliminary results may suggest some therapeutic impact for
patients who underwent TEMLA and subsequent R0 resection, with
a 77.2% survival rate after the mean 24-month follow-up period.
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INDICATIONS
We studied patients with proven non-small cell lung
cancer (NSCLC) who were candidates for pulmonary resec-
tion, regardless of the state of the mediastinal nodes on
computed tomography (CT) or positron emission tomogra-
phy/CT. CT was performed for all patients; however, positron
emission tomography/CT could be performed for only some
of our most recent patients. All patients with lymph nodes
enlarged on CT underwent transbronchial needle aspiration
(TBNA). TEMLA was performed for patients with a negative
result of TBNA.
TECHNIQUE
The operative technique included a 5- to 8-cm collar
incision in the neck, elevation of the sternal manubrium with
a special retractor, bilateral visualization of the laryngeal
recurrent and vagus nerves, and dissection of all mediastinal
nodal stations except for the pulmonary ligament nodes
(station 9) and the most distal left paratracheal nodes (station
4L).1–4 Most of the procedure is open, with the subcarinal and
the periesophageal nodes (stations 7 and 8) removed with
mediastinoscopy-assisted technique and the para-aortic and
the pulmonary-window nodes (stations 6 and 5) removed
with videothoracoscopy-assisted technique, with the video-
thoracoscope inserted through the transcervical incision.
Generally, the mediastinal pleura is not violated, and no drain
is left in the mediastinum. In the case of opening of the
mediastinal pleura during surgery, there is no need for pleural
drainage; hyperinflation of the lungs by the anesthesiologist
during closure of the wound at the end of a procedure and
insertion of a piece of fibrin sponge near the place of lacer-
ation of the pleura are sufficient.
RESULTS
There were 256 patients: 218 men and 38 women aged
41 to 79 years (mean age, 60.8 years). There were 176
squamous cell carcinomas, 51 adenocarcinomas, 8 large cell
carcinomas, and 21 others. Preoperative stage was cI in 134,
cII in 31, cIII in 89, and cIV in 2 patients. Length of operation
was 80 to 330 minutes (mean, 161 minutes). There were no
intraoperative injuries of the vitally important structures,
including major vessels, tracheobronchial tree, or the esoph-
agus. There were three postoperative deaths unrelated to the
procedure (mortality, 1.2%). Complication of TEMLA oc-
curred in 11.3% of patients, with temporary laryngeal nerve
palsy in 6 of 256 patients (2.3%) and permanent nerve palsy
in 2 of 256 patients (0.8%). Pneumothorax necessitating
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pleural drainage occurred in 1 of 256 patients (0.4%) and
pleural effusion in 11 of 256 patients (4.3%). Asymptomatic
widening of the mediastinum was noted in 60% of patients. It
necessitated no treatment, subsided after several days, and
was not regarded as a postoperative complication.
The number of dissected nodes during TEMLA was 15
to 85 (mean, 38.9) (Tables 1 and 2). N2 nodes were found in
80 patients (31.3%). Metastatic nodes were discovered in
station 7 (41 pf 80 patients with N2-3), station 4R (27 of 80),
stations 5 and 2R (15 of 80), station 4L (14 of 80), station 8
(11 of 80), station 6 (7 of 80), station 3A (5 of 80), station 1
(2 of 80), and station 2L (1 of 80). No metastatic nodes were
discovered in station 3P, which is a highly variable station;
most often it contains no nodes. Stations 5 and 6 were
involved in a case of right-sided tumors, and station 3A was
never involved in a case of left-sided tumors. N2-3 was
one-level in 51 patients (63.8%), two-level in 13 patients,
three-level in 9 patients, four-level in 3 patients, five-level in
1 patient, six-level in 1 patient, seven-level in 1 patient, and
eight-level in 1 patient. There were 138 thoracotomies, in-
cluding 30 pneumonectomies, 13 sleeve lobectomies, 84
lobectomies/bilobectomies, 2 sublobar resections, and 9 ex-
plorations (6.5%). During thoracotomy, omitted N2 was
found in 5 of 138 patients, and omitted normal mediastinal
nodes were found in 13 of 138 patients (9.4%). Omitted N2
nodes were found in station 5 (two patients), station 4L (one
patient), station 7 (one patient), and station 4R (one patient).
The reasons for leaving these nodes were dependent on the
learning curve; in the last 150 TEMLA procedures, there
were no false-negative results. Postoperative mortality after
thoracotomy was 3 of 138 (2.2%). Sensitivity of TEMLA in
the discovery of N2-3 nodes was 94.1%, specificity was
100%, accuracy was 98%, negative predictive value was
97.2%, and positive predictive value was 100%. In the last
150 patients, all these parameters were 100%. In 16 of 80
patients with positive N2-3 nodes on TEMLA and neo-
adjuvant chemotherapy or chemoradiotherapy, subsequent
thoracotomy was performed and was technically feasible.
This number is small because of the problems with referring
the patients who underwent neoadjuvant therapy for repeated
surgical consultation. The operative procedures included five
pneumonectomies, two sleeve lobectomies, eight lobecto-
mies/bilobectomies, and one exploratory thoracotomy. There
were 13 of 15 R0 resections and 2 R1 resections. In patients
with N2/N3 tumors proven by complete TEMLA and treated
with subsequent neo-adjuvant chemotherapy or chemoradio-
therapy, no invasive restaging of the lymph nodes of the
mediastinum was necessary, with the exception of TBNA. In
our recently presented prospective randomized trial (EACTS/
ESTS joint meeting, Stockholm, 2006), the diagnostic accu-
racy of TEMLA proved to be statistically better than that of
standard mediastinoscopy (sensitivity 100% vs. 37.5%; neg-
ative predictive value 100% vs. 66.7%; P  0.05).5 The
impairment of pulmonary function after TEMLA and stan-
dard mediastinoscopy was not statistically different.6 Possible
higher postoperative mortality and morbidity of pulmonary
resections after prior TEMLA was our concern. However, the
postoperative mortality in 2004, the first year TEMLA was
used, was 4.3%, and in the years 2005 to 2006, the postop-
erative mortality decreased to 0.4% (1 of 224). In 2002 to
2003, before the introduction of TEMLA, the postoperative
mortality in our department was 3.5%. Because of more
accurate preoperative staging, there was a 25% decrease of
the number of pulmonary resections for NSCLC after the
introduction of TEMLA. In addition to staging of NSCLC,
TEMLA might have a positive therapeutic impact. Our
preliminary results are encouraging. After a follow-up of
12 to 34 months (mean, 24 months), the survival rate for
patients who underwent radical R0 pulmonary resection
after a prior negative result of TEMLA was 77.2%. Addition-
ally, the locoregional recurrence occurred in only one patient,
whereas all other recurrences occurred in the distal organs.
Implications for Clinical Practice
TEMLA proved to be a safe procedure and had an
improved negative predictive value compared with current
invasive surgical techniques of mediastinal staging. The tech-
nique of TEMLA can be extended to remove the supracla-
vicular and deep cervical nodes bilaterally. The technique of
TEMLA is a part of the transcervical-subxiphoid-VATS max-
imal thymectomy for myasthenia gravis. In fact, the tech-
nique of TEMLA originated from the technique of thymec-
tomy, which was introduced by the author in 2000. The other
uses of the technique of TEMLA include resection of medi-
TABLE 1. Number of Metastatic Lymph Node Stations
(levels) Involvement
Number of Metastatic Lymph
Node Stations Levels
Number of Patients With
Metastatic Nodes (%)
1 level 51 (63.8%)
2 level 13 (16.3%)
3 level 9 (11.3%)
4 level 3 (3.8%)
5 level 1 (1.3%)
6 level 1 (1.3%)
7 level 1 (1.3%)
8 level 1 (1.3%)
TABLE 2. Number of Patients with Metastatic Involvement
of the Specific Mediastinal Lymph Node Stations
Mediastinal Lymph Node
Station Number
Number of Patients With
Metastatic Nodes
1 2
2R 15
4R 27
3A 5
3P 0
2L 1
4L 14
5 19
6 7
7 41
8 11
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astinal tumors, resection of metastatic nodes to the mediasti-
num, and esophageal resection with three-field lymphadenec-
tomy (combined with laparotomy or laparoscopy).
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